Clinical Trial Update: Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating antivascular therapy in combination with chemotherapy versus chemotherapy alone as adjuvant treatment for triple-negative brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer, Triple Negative Breast Cancer | Phase 3 | Status: RECRUITING